These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 1636057
1. In vivo studies on halogen compound interactions. IV. Interaction among different halogen derivatives with and without synergistic action on liver toxicity. Danni O, Aragno M, Tamagno E, Ugazio G. Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):355-66. PubMed ID: 1636057 [Abstract] [Full Text] [Related]
4. Change of liver metabolism of 1,2-dibromoethane during simultaneous treatment with carbon tetrachloride. Chiarpotto E, Biasi F, Aragno M, Scavazza A, Danni O, Albano E, Poli G. Cell Biochem Funct; 1993 Mar; 11(1):71-5. PubMed ID: 8453739 [Abstract] [Full Text] [Related]
5. Acetaldehyde involvement in ethanol-induced potentiation of rat hepatocyte damage due to the carcinogen 1,2-dibromoethane. Chiarpotto E, Biasi F, Scavazza A, Camandola S, Aragno M, Tamagno E, Danni O, Dianzani MU, Poli G. Alcohol Alcohol; 1995 Nov; 30(6):721-8. PubMed ID: 8679012 [Abstract] [Full Text] [Related]
9. Response of endogenous reduced glutathione through hepatic glutathione redox cycle to enhancement of hepatic lipid peroxidation with the development of acute liver injury in mice intoxicated with carbon tetrachloride. Nishida K, Ohta Y, Kongo M, Ishiguro I. Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):198-218. PubMed ID: 8884991 [Abstract] [Full Text] [Related]
12. In vivo studies on halogen compound interactions. II. Effects of carbon tetrachloride plus 1,2-dibromoethane on relative liver weight and hepatic steatosis. Aragno M, Danni O, Ugazio G. Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):105-16. PubMed ID: 2616892 [Abstract] [Full Text] [Related]
14. Ethanol-induced potentiation of rat hepatocyte damage due to 1,2-dibromoethane. Chiarpotto E, Biasi F, Aragno M, Scavazza A, Danni O, Dianzani MU, Poli G. Alcohol Alcohol; 1995 Jan; 30(1):37-45. PubMed ID: 7748274 [Abstract] [Full Text] [Related]
15. The use of human in vitro metabolic parameters to explore the risk assessment of hazardous compounds: the case of ethylene dibromide. Ploemen JP, Wormhoudt LW, Haenen GR, Oudshoorn MJ, Commandeur JN, Vermeulen NP, de Waziers I, Beaune PH, Watabe T, van Bladeren PJ. Toxicol Appl Pharmacol; 1997 Mar; 143(1):56-69. PubMed ID: 9073592 [Abstract] [Full Text] [Related]
16. Urinary thiodiacetic acid. A selective biomarker for the cytochrome P450-catalyzed oxidation of 1,2-dibromoethane in the rat. Wormhoudt LW, Commandeur JN, Ploemen JH, Abdoelgafoer RS, Makansi A, Van Bladeren PJ, Vermeulen NP. Drug Metab Dispos; 1997 Apr; 25(4):508-15. PubMed ID: 9107551 [Abstract] [Full Text] [Related]
17. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat. Raiford DS, Thigpen MC. Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494 [Abstract] [Full Text] [Related]
18. Rapid, substrate-specific, and dose-dependent deactivation of liver cytosolic glutathione S-transferases in vivo by 1,1-dichloroethylene. Moslen MT, Reynolds ES. Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):59-72. PubMed ID: 3983471 [Abstract] [Full Text] [Related]
19. In vitro metabolism of 1,2-dihaloethanes to ethylene. Livesey JC, Anders MW. Drug Metab Dispos; 1979 Jan; 7(4):199-203. PubMed ID: 39719 [Abstract] [Full Text] [Related]
20. Attenuation of disrupted hepatic active oxygen metabolism with the recovery of acute liver injury in rats intoxicated with carbon tetrachloride. Ohta Y, Nishida K, Sasaki E, Kongo M, Ishiguro I. Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):191-207. PubMed ID: 9090755 [Abstract] [Full Text] [Related] Page: [Next] [New Search]